Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing
- PMID: 3080012
- PMCID: PMC1232115
- DOI: 10.1136/hrt.55.2.181
Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing
Abstract
The effects of long term (4 weeks) treatment with oral metoprolol (100 mg twice daily) and sotalol (160 mg twice daily) on ventricular repolarisation time were compared in a double blind crossover study in 20 patients post-infarction. For QT interval studies transoesophageal atrial pacing was performed at a cycle length of 800 ms. Sotalol prolonged the QT interval by 5-7% compared with metoprolol. The prolongation reflects a change in the repolarisation time because there was no change in the QS interval. Measurements of heart rate at rest and during bicycle exercise indicated that metoprolol and sotalol in the doses selected were equipotent as beta blockers. Transoesophageal atrial pacing is a simple non-invasive method with few and mild side effects that is well suited to drug studies.
Similar articles
-
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.Drugs. 1993 Oct;46(4):678-719. doi: 10.2165/00003495-199346040-00007. Drugs. 1993. PMID: 7506652 Review.
-
Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.Europace. 2001 Jan;3(1):73-9. doi: 10.1053/eupc.2000.0140. Europace. 2001. PMID: 11271956 Clinical Trial.
-
Acute and chronic effects of sotalol and propranolol on ventricular repolarization using constant-rate pacing.Am J Cardiol. 1986 May 1;57(13):1092-6. doi: 10.1016/0002-9149(86)90680-6. Am J Cardiol. 1986. PMID: 3518383 Clinical Trial.
-
Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery.J Cardiovasc Pharmacol. 1998 Jan;31(1):67-73. doi: 10.1097/00005344-199801000-00010. J Cardiovasc Pharmacol. 1998. PMID: 9456279 Clinical Trial.
-
Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.Drugs. 1995 May;49(5):664-79. doi: 10.2165/00003495-199549050-00003. Drugs. 1995. PMID: 7601009 Review.
Cited by
-
Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing.Cardiovasc Drugs Ther. 1991 Aug;5 Suppl 4:819-25. doi: 10.1007/BF00120830. Cardiovasc Drugs Ther. 1991. PMID: 1931758
-
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.Drugs. 1993 Oct;46(4):678-719. doi: 10.2165/00003495-199346040-00007. Drugs. 1993. PMID: 7506652 Review.
-
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Drugs. 1987 Sep;34(3):311-49. doi: 10.2165/00003495-198734030-00002. Drugs. 1987. PMID: 3315621 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources